Colchicine
- Generic Name
- Colchicine
- Brand Names
- Colcrys, Gloperba, Lodoco, Mitigare
- Drug Type
- Small Molecule
- Chemical Formula
- C22H25NO6
- CAS Number
- 64-86-8
- Unique Ingredient Identifier
- SML2Y3J35T
- Background
Colchicine is an alkaloid drug derived from a plant belonging to the Lily family, known as Colchicum autumnale, or "autumn crocus." Its use was first approved by the FDA in 1961. Colchicine is used in the treatment of gout flares and Familial Mediterranean fever, and prevention of major cardiovascular events. It has also been investigated in other inflammato...
- Indication
Colchicine is indicated for the prophylaxis and treatment of gout flares. It is also indicated in Familial Mediterranean fever (FMF) in children and adults of four years of age and older. It is also indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established ather...
- Associated Conditions
- Behcet's Syndrome, Cardiovascular Mortality, Coronary Revascularization, Familial Mediterranean Fever (FMF ), Gout Flares, Myocardial Infarction, Pericarditis, Postpericardiotomy Syndrome, Stroke
- Associated Therapies
- -
Targeting Inflammation in Acute Coronary Syndrome Using Colchicine
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT00754819
- Locations
- 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada
Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2008-07-29
- Lead Sponsor
- Mashhad University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT00723268
- Locations
- 🇮🇷
Mashhad Dental school, Mashhad, Khorasan Razavi, Iran, Islamic Republic of
Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2008-06-18
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 169
- Registration Number
- NCT00700297
- Locations
- 🇮🇷
Rheumatology research Center, Tehran UMS, Tehran, Iran, Islamic Republic of
Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
- Conditions
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2006-10-09
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370201
- Locations
- 🇮🇷
Hamid Ahmadieh,MD, Tehran, Iran, Islamic Republic of
Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Azienda Sanitaria Locale 3, Torino
- Target Recruit Count
- 240
- Registration Number
- NCT00235079
- Locations
- 🇮🇹
Cardiology Department. Maria Vittoria Hospital ASL3 Torino (Coordinating Center), Torino, Italy
🇮🇹Ospedale Regionale, Bolzano, Italy
🇮🇹Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
Study of Long-term Peg Intron vs. Colchicine in Non-responders.
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 549
- Registration Number
- NCT00179413
- Locations
- 🇺🇸
Southern Clinical Research Consultants, Hollywood, Florida, United States
🇺🇸Lahey Clinic, Burlington, Massachusetts, United States
🇺🇸Fallon Clinic, Worcester, Massachusetts, United States
Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
- Conditions
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 90
- Registration Number
- NCT00004748
Asthma Clinical Research Network (ACRN)
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- Milton S. Hershey Medical Center
- Registration Number
- NCT00000577
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸University of California at San Diego, La Jolla, California, United States
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 15
- Registration Number
- NCT00004368
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.